TWO SIGMA ADVISERS, LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,839,723
+107.5%
142,900
+175.3%
0.01%
+100.0%
Q2 2023$1,850,754
+127.7%
51,900
+62.2%
0.01%
+150.0%
Q1 2023$812,800
-35.8%
32,000
+57.6%
0.00%
-33.3%
Q3 2021$1,267,000
-71.6%
20,300
-62.3%
0.00%
-75.0%
Q2 2021$4,456,000
-32.7%
53,800
-46.1%
0.01%
-33.3%
Q1 2021$6,618,000
+59.1%
99,800
+84.1%
0.02%
+63.6%
Q4 2020$4,159,000
-50.5%
54,200
-72.2%
0.01%
-54.2%
Q3 2020$8,410,000
-70.6%
195,300
-70.5%
0.02%
-71.4%
Q2 2020$28,639,000
+59.1%
663,100
+6.0%
0.08%
+21.7%
Q1 2020$17,996,000
+84.0%
625,500
+305.6%
0.07%
+200.0%
Q4 2019$9,781,000
+233.7%
154,200
+48.3%
0.02%
+228.6%
Q3 2019$2,931,000
-54.4%
104,000
-57.1%
0.01%
-56.2%
Q2 2019$6,424,000
+368.6%
242,400
+224.5%
0.02%
+433.3%
Q1 2019$1,371,000
+258.0%
74,700
+273.5%
0.00%
+200.0%
Q3 2018$383,00020,0000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders